ZA898018B - Treatment of osteoporosis - Google Patents

Treatment of osteoporosis

Info

Publication number
ZA898018B
ZA898018B ZA898018A ZA898018A ZA898018B ZA 898018 B ZA898018 B ZA 898018B ZA 898018 A ZA898018 A ZA 898018A ZA 898018 A ZA898018 A ZA 898018A ZA 898018 B ZA898018 B ZA 898018B
Authority
ZA
South Africa
Prior art keywords
potassium
preferred
osteoporosis
treatment
methods
Prior art date
Application number
ZA898018A
Other languages
English (en)
Inventor
R Curtis Morris Jr
Curtis Morris R Jr
Anthony Sebastian
Sebastian Anthony
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of ZA898018B publication Critical patent/ZA898018B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA898018A 1988-10-21 1989-10-23 Treatment of osteoporosis ZA898018B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26085688A 1988-10-21 1988-10-21

Publications (1)

Publication Number Publication Date
ZA898018B true ZA898018B (en) 1990-12-28

Family

ID=22990921

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA898018A ZA898018B (en) 1988-10-21 1989-10-23 Treatment of osteoporosis
ZA898017A ZA898017B (en) 1988-10-21 1989-10-23 Treatment of hypertension

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA898017A ZA898017B (en) 1988-10-21 1989-10-23 Treatment of hypertension

Country Status (13)

Country Link
US (1) US5804204A (da)
EP (3) EP0440738B1 (da)
JP (2) JP2843146B2 (da)
KR (2) KR0163583B1 (da)
AT (1) ATE145825T1 (da)
AU (2) AU634988B2 (da)
CA (2) CA2001124C (da)
DE (2) DE68913311T2 (da)
DK (2) DK175841B1 (da)
HU (2) HU212106B (da)
IL (2) IL92076A (da)
WO (2) WO1990004402A1 (da)
ZA (2) ZA898018B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674529A (en) * 1995-06-06 1997-10-07 Church & Dwight Co., Inc. Alkalinizing potassium salt controlled release preparations
AT408416B (de) * 1996-07-19 2001-11-26 Norbert Fuchs Pharmazeutische bzw. diätetische zusammensetzungen
EP1350515A1 (en) * 2002-04-05 2003-10-08 Btg International Limited Low-dose potassium supplementation for the prevention and treatment of hypertension
AU2003219321A1 (en) * 2002-04-05 2003-10-27 Btg International Limited Low-dose potassium supplementation for the prevention and treatment of hypertension
US20040202726A1 (en) * 2003-04-10 2004-10-14 Deshay Samuel L. Topical blood pressure composition
US10251909B2 (en) * 2007-02-09 2019-04-09 Board Of Regents, The University Of Texas System Potassium-magnesium citrate as a surrogate of the DASH diet in managing hypertension
US20090022853A1 (en) * 2007-07-16 2009-01-22 Conopco, Inc., D/B/A Unilever Beverage
US20090196957A1 (en) * 2008-02-06 2009-08-06 Campbell Soup Company Methods and compositions for reducing sodium content in food products
US20110195172A1 (en) * 2008-09-05 2011-08-11 Inge Elisabeth Maria Deutz Beverages comprising potassium
CN114272263A (zh) * 2022-01-10 2022-04-05 伍永田 一种用于治疗高血压疾病的水配方

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2611730A (en) * 1950-09-02 1952-09-23 Simth Kline & French Lab Medical preparation for reducing the body level of sodium
GB1195381A (en) * 1967-04-28 1970-06-17 Arthur H Cox & Company Ltd Pharmaceutical Compositions Comprising Potassium and Chlorine
US3639585A (en) * 1968-03-29 1972-02-01 Res Inst Medicine Chem Method of preventing corticosteroid-induced adverse effects on bon and compositions useful in said method
US3541208A (en) * 1968-09-10 1970-11-17 Arcom Holding Corp Relief of arthritis with a soluble silicate and a soluble polyphosphate
US3921804A (en) * 1974-05-09 1975-11-25 William W Tester Medication dispensing package
SU858830A1 (ru) * 1974-10-23 1981-08-30 Институт медико-биологических проблем Средство дл лечени нарушений ритма сердца
SU946545A1 (ru) * 1978-05-04 1982-07-30 Институт Медико-Биологических Проблем Министерства Здравоохранения Ссср Способ восполнени калиевого дефицита в ткан х
FR2432869A1 (fr) * 1978-08-08 1980-03-07 Armour Montagu Laboratoire Compositions pour le traitement de l'osteoporose associant la calcitonine et le phosphore
US4289750A (en) * 1978-10-16 1981-09-15 Kopp Klaus F Therapy of conditions which may be associated with altered renal function and dosage forms therefor
US4405596A (en) * 1978-10-16 1983-09-20 Helbig Joachim W Pharmaceutical preparations for and treatment procedures involving increasing plasma bicarbonate level
US4451454A (en) * 1981-06-16 1984-05-29 Wong Dennis W Prophylaxis and treatment of thromboembolic disorders in man and in warm-blooded animals with bicarbonate salts of alkali metals
US4704269A (en) * 1985-06-11 1987-11-03 Hudson Pharmaceutical Corporation Effervescent antacid and analgesic compositions
JPH0619063B2 (ja) * 1986-04-09 1994-03-16 日本エステル株式会社 粉体塗料用樹脂組成物

Also Published As

Publication number Publication date
JP2843146B2 (ja) 1999-01-06
DE68913311D1 (de) 1994-03-31
HU896567D0 (en) 1991-07-29
HU896889D0 (en) 1991-07-29
DK72691A (da) 1991-04-22
EP0440738B1 (en) 1996-12-04
HU212106B (en) 1996-02-28
IL92076A (en) 1995-08-31
WO1990004402A1 (en) 1990-05-03
JPH04501419A (ja) 1992-03-12
CA2001124C (en) 2000-01-18
IL92076A0 (en) 1990-07-12
HU208923B (en) 1994-02-28
KR0163583B1 (ko) 1998-12-01
AU634988B2 (en) 1993-03-11
DE68927519D1 (de) 1997-01-16
IL92075A0 (en) 1990-07-12
ATE145825T1 (de) 1996-12-15
CA2001123C (en) 2000-01-18
CA2001124A1 (en) 1990-04-21
WO1990004403A1 (en) 1990-05-03
DE68927519T2 (de) 1997-04-03
DK72791D0 (da) 1991-04-19
DK175840B1 (da) 2005-03-29
AU4622089A (en) 1990-05-14
DK72691D0 (da) 1991-04-19
HUT57989A (en) 1992-01-28
EP0440738A1 (en) 1991-08-14
ZA898017B (en) 1990-12-28
CA2001123A1 (en) 1990-04-21
IL92075A (en) 1995-07-31
HUT63058A (en) 1993-07-28
KR0178033B1 (ko) 1999-03-20
AU635231B2 (en) 1993-03-18
JP2948247B2 (ja) 1999-09-13
DE68913311T2 (de) 1994-05-26
EP0461111B1 (en) 1994-02-23
AU4515489A (en) 1990-05-14
DK175841B1 (da) 2005-03-29
EP0720855A2 (en) 1996-07-10
JPH04501724A (ja) 1992-03-26
KR900701287A (ko) 1990-12-01
EP0720855A3 (en) 1998-07-08
DK72791A (da) 1991-05-14
KR900701288A (ko) 1990-12-01
US5804204A (en) 1998-09-08
EP0461111A4 (en) 1991-07-25
EP0440738A4 (en) 1991-08-28
EP0461111A1 (en) 1991-12-18

Similar Documents

Publication Publication Date Title
IT8419266A1 (it) Dispositivo per generare calore in tessuti" del corpo umano e procedimento di cenerazione di calore, particolarmente per la cura di tumori
EP0787802A3 (da)
ID24901A (id) Metode pengobatan keadaan terkoagulasi tinggi atau defisiensi protein c yang diperoleh
JPS57193412A (en) Prevention of prostatic hyperplasia and therapeutical drug
HU896889D0 (en) Treatment of osteoporosis
PL323798A1 (en) Application of derivatives of vitamin d4 in treating skin diseases
GR3037031T3 (en) Dermatological preparation and method for treating actinic keratoses
KR970009582B1 (en) Method for the treatment of oste oporosis and related disorders
EA200000686A1 (ru) Препараты левозимендана, предназначенные для введения через слизистую оболочку
EP0350738A3 (de) (S)-Emopamil zur Anwendung bei der Behandlung von Migräne
GR3000751T3 (en) Tpa-containing medical composition and use thereof
GR3022608T3 (en) USE OF (E)-2-(p-FLUOROPHENETHYL)-3-FLUOROALLYLAMINE IN THE TREATEMENT OF ALZHEIMER'S DISEASE.
GR3006147T3 (da)
EP0144489A3 (en) Cerebral and peripheral antihypoxidoticum
GEP19981480B (en) Method for Treating Vertebral Column
IT1246050B (it) Impiego dell'eptastigmina nella terapia dell'ictus cerebrale.
MY117556A (en) Methods and formulations for modulating the human sexual response
BG51278A1 (en) Method for potentiation of the therapeutical effect of human recombination erythropoietin
UA30125A (uk) Спосіб лікування дітей з ревматоїдним артритом та дифузними хворобами сполучної тканини
ES8401719A1 (es) "procedimiento para mejorar la vision".
UA10000A (uk) Спосіб лікування гострої недостатності тканинного дихання
UA26407C2 (uk) Спосіб очищеhhя уражеhих шкірhих покривів людиhи при захворюваhhі псоріазом
RU93032381A (ru) Способ лечения хронического описторхоза
IE871907L (en) "methods for treatment of sundamaged human skin with¹retinoids"
GEP19991514B (en) Method for Treatment with Interferon